Financials outStill losing money...
but
"On October 31, 2016, the Company announced it had received $240,534 from YuTian Technology to purchase the first batch of components to begin the manufacturing process of the VMS-PLUS heart analysis units in China. Thus, the Company with its Chinese Partners is accessing the market in China. This is a major milestone as the opportunity in China continues to expand and we feel with manufacturing now beginning, the Company is in a position to drive tremendous value for our shareholders in the quarters to come. The first machines are expected to be constructed by the end of the year and will be used to facilitate the submission to the Chinese FDA for marketing approval, as well as to demonstrate the machine to distributors in China. Our Chinese partners are establishing a distribution network for all of China."
"In addition, the Company is evaluating the integration of its technology with existing ultrasound devices and analysis packages. The Company continues to discuss with manufacturers of ultrasound equipment and analytic software the merits of combining the VMS with their systems to allow for a complete heart analysis using 2D ultrasound. The Company will disclose any agreements, to the limit possible for such commercial agreements, should they arise."